TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ)

$1.14 -0.05 (-4.2017%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 77

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ) News Sources

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells

25-11-2025

yahoo.com

Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models

05-01-2026

yahoo.com

Telomir Pharmaceuticals Announces FDA Clearance of IND for Telomir-Zn in Triple-Negative Breast Cancer

30-04-2026

yahoo.com

Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma

14-04-2026

yahoo.com

Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models

10-08-2026

yahoo.com

Telomir Pharmaceuticals Submits IND to FDA for Telomir-1 (Telomir-Zn) in Advanced and Metastatic Triple-Negative Breast Cancer

31-03-2026

yahoo.com

Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1 (Telomir-Zn)

24-04-2026

yahoo.com

Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease

20-05-2026

yahoo.com

Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensitivity with Telomir-Zn in a Preclinical Type 2 Diabetes Model

15-06-2026

yahoo.com

TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ) Sentiment Trend

0 25 50 75 100 77 60 78 79 81 81 66 82 89 25-11-2025 05-01-2026 30-04-2026 14-04-2026 10-08-2026 31-03-2026 24-04-2026 20-05-2026 15-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ) FAQs

toggle

What is the current price of TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ)?

The current price of TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ) is $1.14.


toggle

TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ) absolute price change since previous trading day?

The absolute price change of TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ) since the previous trading day is $-0.05.


toggle

TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ) percentage price change since previous trading day?

The percentage price change of TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ) since the previous trading day is -4.2017%.


toggle

What is the most recent average sentiment score for TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ)?

The most recent average sentiment score for TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ) is 77 out of 100.


toggle

What is the most recent average sentiment for TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ)?

The most recent sentiment for TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ) is .


SEC-8K** Filing Available For TELOMIR PHARMACEUTICALS INC (TELO:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.